Abstract
DC-SIGN is a calcium dependent lectin that binds to HIV envelope, gp120, with high affinity. Its expression on dendritic cells, coupled with its ability to facilitate the binding and subsequent transfer of virions to permissive T-cells, has led to the hypothesis that DC-SIGN may serve as a conduit the transfer of HIV from the peripheral mucosa to secondary lymphoid organs. Studies have shown that DC-SIGN bound virions can maintain their infectivity for prolonged periods of time despite evidence that DC-SIGN itself may serve as an antigen receptor. How HIV subverts the normal function of DC-SIGN to establish a primary infection in the host is unclear. Therefore, understanding the structural and immunological basis for DCSIGNs function will help us realize the role that DC-SIGN may play in viral transmission and pathogenesis. Importantly, DC-SIGN / envelope interactions may represent a new target for microbicide and vaccine development efforts. Here, we review recent studies on DC-SIGNs structure and function in an effort to present testable models of DC-SIGNs role in HIV pathogenesis.
Keywords: dc-sign, c-type lectins, dendritic cells, viral attachment, endocytic receptor, hiv transmission
Current HIV Research
Title: Sugar and Spice: Viral Envelope-DC-SIGN Interactions in HIV Pathogenesis
Volume: 1 Issue: 1
Author(s): Stephen V. Su, Kevin B. Gurney and Benhur Lee
Affiliation:
Keywords: dc-sign, c-type lectins, dendritic cells, viral attachment, endocytic receptor, hiv transmission
Abstract: DC-SIGN is a calcium dependent lectin that binds to HIV envelope, gp120, with high affinity. Its expression on dendritic cells, coupled with its ability to facilitate the binding and subsequent transfer of virions to permissive T-cells, has led to the hypothesis that DC-SIGN may serve as a conduit the transfer of HIV from the peripheral mucosa to secondary lymphoid organs. Studies have shown that DC-SIGN bound virions can maintain their infectivity for prolonged periods of time despite evidence that DC-SIGN itself may serve as an antigen receptor. How HIV subverts the normal function of DC-SIGN to establish a primary infection in the host is unclear. Therefore, understanding the structural and immunological basis for DCSIGNs function will help us realize the role that DC-SIGN may play in viral transmission and pathogenesis. Importantly, DC-SIGN / envelope interactions may represent a new target for microbicide and vaccine development efforts. Here, we review recent studies on DC-SIGNs structure and function in an effort to present testable models of DC-SIGNs role in HIV pathogenesis.
Export Options
About this article
Cite this article as:
Su V. Stephen, Gurney B. Kevin and Lee Benhur, Sugar and Spice: Viral Envelope-DC-SIGN Interactions in HIV Pathogenesis, Current HIV Research 2003; 1 (1) . https://dx.doi.org/10.2174/1570162033352129
DOI https://dx.doi.org/10.2174/1570162033352129 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Kv7 Channels as Targets for the Treatment of Pain
Current Pharmaceutical Design PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation
Pharmaceutical Nanotechnology Indications for Surgery and Operative Techniques in Infective Endocarditis in the Present Day
Infectious Disorders - Drug Targets The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction
Current Pharmaceutical Design Role of Nitrosative Stress and Activation of Poly(ADP-ribose) Polymerase-1 in Cardiovascular Failure Associated with Septic and Hemorrhagic Shock
Current Vascular Pharmacology Effects of Flavonoids in Experimental Models of Arterial Hypertension
Current Topics in Medicinal Chemistry Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Current Pharmaceutical Design HSP60 as a Drug Target
Current Pharmaceutical Design Recent Progress in the Development of Natural ent-Kaurane Diterpenoids with Anti-tumor Activity
Mini-Reviews in Medicinal Chemistry The Use of Thiazides in Chronic Kidney Disease
Current Hypertension Reviews Molecular Modeling and Simulation of Membrane Lipid-Mediated Effects on GPCRs
Current Medicinal Chemistry Natural and Synthetic Retinoids: Structural Bases and Biological Effects of Potential Clinical Relevance for the Prevention and Treatment of Infection-Driven Tumors
Anti-Infective Agents in Medicinal Chemistry Unusual Food Allergy: AlioideaAllergic Reactions Overview
Recent Patents on Inflammation & Allergy Drug Discovery Asymmetric Dimethylarginine (ADMA) and Cardiovascular Disease
Vascular Disease Prevention (Discontinued) Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Treating Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit
Current Vascular Pharmacology Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade
Recent Patents on Anti-Cancer Drug Discovery Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review
Current Medicinal Chemistry Plasma Gelsolin: Function, Prognostic Value, and Potential Therapeutic Use
Current Protein & Peptide Science The Multiple Layers of Signaling Selectivity at Protease-Activated Receptors
Current Pharmaceutical Design